Study to Evaluate the Safety and Efficacy of Prolastin in Hospitalized Subjects With COVID-19

NCT04495101 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19

Interventions

BIOLOGICAL: Prolastin
DRUG: Standard Medical Treatment

Sponsor

Instituto Grifols, S.A.